Compounded versions of GLP-1 receptor agonists are not FDA-approved and can increase the risk of contamination when purchased from unreliable sources
A Randomized, controlled trial of 3.0 mg of liraglutide in weight management
Sitagliptl differs in chemical structure and pharmacological action from GLP-I analogues, insulin, sulfonylurea derivatives or meglitinides, biguanides, peroxisome proliferator-activated receptor y-receptor agonists (PPARY), alphaglucosidase inhibitors and amylin analogues
Individual variation in hormone production and sensitivity means that some people may benefit more from comprehensive supplementation while others see adequate results from basic interventions
Moving Forward with FSA/HSA Approved Weight Loss Success As you begin your GLP-1 medication weight loss journey, remember that proper planning especially during open enrollment, where you can maximize your savings with FSA/HSA benefits and GLP-1 medications, can make treatment more affordable and accessible